John M. Davis, MD
- 17Articles
- 63.3KReads1
- 1997–2025Active
- 68Collaborators
- 207Citations2
About
John M. Davis, MD, affiliated with the Department of Psychiatry at the University of Illinois, Chicago, has published extensively on schizophrenia and schizoaffective disorders, bipolar disorder, and related metabolic and behavioral issues. His work includes clinical trials investigating adjunctive treatments such as sulforaphane, pramipexole, and raloxifene in schizophrenia, as well as studies on the metabolic effects of antipsychotics. Davis has also contributed to research on polyunsaturated fatty acids in bipolar disorder and the safety profiles of antipsychotic medications. His publications span from 1997 to 2025 in peer-reviewed outlets including Psychiatrist.com.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
